1-4 of 4
Karin E. Smedby
Close
Sort by
Journal Articles

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation

Clinical Trials & Observations
Sara Ekberg, Karin E. Smedby, Alexandra Albertsson-Lindblad, Mats Jerkeman, Caroline E. Weibull, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2023) 7 (5): 866–874.
https://doi.org/10.1182/bloodadvances.2022007241
Published: 2023
Includes: Supplemental data
Journal Articles

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study

Joel Joelsson, Tove Wästerlid, Richard Rosenquist, Lasse Hjort Jakobsen, Tarec C. El-Galaly, Karin E. Smedby, Sandra Eloranta
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2657–2666.
https://doi.org/10.1182/bloodadvances.2021006369
Published: 2022
Includes: Supplemental data
Journal Articles

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Alex Reza Gholiha, Peter Hollander, Ingrid Glimelius, Gustaf Hedstrom, Daniel Molin, Henrik Hjalgrim, Karin E. Smedby, Jamileh Hashemi, Rose-Marie Amini, Gunilla Enblad
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1671–1681.
https://doi.org/10.1182/bloodadvances.2020003664
Published: 2021
Includes: Supplemental data
Journal Articles

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival

Clinical Trials & Observations
Ingrid Glimelius, Karin E. Smedby, Alexandra Albertsson-Lindblad, Michael J. Crowther, Sandra Eloranta, Mats Jerkeman, Caroline E. Weibull
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1638–1647.
https://doi.org/10.1182/bloodadvances.2020003645
Published: 2021
Includes: Supplemental data